Alpha Cognition Inc. is experiencing a notable increase in stock ownership as Opaleye Management Inc. has acquired additional shares. This development is significant as it indicates investor confidence in Alpha Cognition, a company that operates within the biological products sector.
According to a recent SEC filing, Opaleye Management acquired 22,657 shares on October 15, 2026, at an average price of $8.4289 per share. Following this transaction, Opaleye now holds a total of 3,245,611 shares in Alpha Cognition. In a subsequent transaction on October 16, 2026, Opaleye added another 14,283 shares at an average price of $8.2337, bringing their total holdings to 3,259,894 shares.
Background
Alpha Cognition Inc. is categorized under the SIC code 2836, which pertains to Biological Products, (No Diagnostic Substances). The company trades on the Nasdaq under the ticker symbol ACOG. As a smaller reporting company and an emerging growth entity, Alpha Cognition is focused on developing innovative solutions in the life sciences field. Recent filings indicate that the company is actively engaged in the market, reflecting its commitment to growth and development.
What the Filing Says
The filing reveals that Opaleye Management Inc. is a significant stakeholder, having acquired shares in two separate transactions. The first transaction involved the purchase of 22,657 shares, while the second involved an additional 14,283 shares. The filing states, "The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.35 to $8.49." This indicates a strategic approach to share acquisition by Opaleye.
Impact
This increase in ownership by Opaleye Management may influence the dynamics within the biological products industry. With Opaleye being a ten percent owner, their actions could prompt other investors to reassess their positions in Alpha Cognition and similar companies. The heightened interest in Alpha Cognition's shares could lead to increased scrutiny and competition among peers in the biological products market.
What's Next
The filing does not say what happens next regarding further actions from Opaleye Management or Alpha Cognition Inc. However, the ongoing activity suggests that stakeholders will be closely monitoring the company's performance and any potential future transactions.